June 17, 2020 / 4:31 PM / 15 days ago

WHO halts trial of hydroxychloroquine in COVID-19 patients

Boxes of Hydroxychloroquine are seen at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June16, 2020. REUTERS/Yves Herman

GENEVA/LONDON (Reuters) - The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.

“The hydroxychloroquine arm of the SOLIDARITY trial has been stopped,” WHO expert Ana Maria Henao-Restrepo told a news briefing.

Reporting by Mike Shields, Emma Farge and Kate Kelland, editing by Peter Graff and Kevin Liffey

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below